07:00 , Jun 11, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: RNA 3'-terminal phosphate cyclase (RTCA)

Neurology INDICATION: Nerve damage Cell culture, insect and mouse studies suggest inhibiting RTCA could help treat nerve damage. In cultured human hippocampal neurons, overexpression of human RTCA decreased axon complexity and proximal axonal branching compared...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Company News

Roche sales and marketing update

Roche launched its xCELLigence System RTCA HT Instrument worldwide for high throughput analysis for research use. The system is suitable for uninterrupted monitoring of real-time kinetics and processes in living cells. Roche (SIX:ROG; OTCQX:RHHBY), Basel,...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Company News

Roche sales and marketing update

Roche launched its xCELLigence RTCA Cardio Instrument outside the U.S. to monitor cardiac beating and cellular events in real time. The company said the label-free cardiomyocyte cell analyzer, which is for research use only, is...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Company News

Acea Biosciences, Cellular Dynamics, Roche deal

The companies combined CDI's iCell Cardiomyocytes with ACEA's and Roche's xCELLigence RTCA System to develop a tool to evaluate the potential cardiotoxic effects of new and previously marketed cardiac compounds. The tool is in beta...